{"transactions":[{"id":745886,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-08T20:15:26.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":41600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 4, 2027, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":112846,"source":{"system":"sec-edgar","filing":"0001193125-26-261768","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000119312526261768/ownership.xml","form_type":"4"}},{"id":769683,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T20:49:38.000Z","date":"2026-05-18","kind":"gift","planned":false,"acquired":false,"shares":25836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a gift to a charitable organization."}],"balance_after":71246,"source":{"system":"sec-edgar","filing":"0001802653-26-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000180265326000003/ownership.xml","form_type":"4"}},{"id":1109525,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-17T01:10:04.000Z","date":"2025-06-13","kind":"sale","planned":false,"acquired":false,"shares":7000,"price":4.59,"value":32130.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.58 to $4.605, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":97082,"source":{"system":"sec-edgar","filing":"0000950170-25-087025","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025087025/ownership.xml","form_type":"4"}},{"id":1117535,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T21:36:16.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":59225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 5, 2026, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":104082,"source":{"system":"sec-edgar","filing":"0000950170-25-083890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017025083890/ownership.xml","form_type":"4"}},{"id":1361472,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-18T22:45:50.000Z","date":"2024-11-14","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":5.1726,"value":25863.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.15 to $5.195, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":44857,"source":{"system":"sec-edgar","filing":"0000950170-24-128115","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017024128115/ownership.xml","form_type":"4"}},{"id":1506844,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-21T20:53:14.000Z","date":"2024-05-17","kind":"grant","planned":false,"acquired":true,"shares":37578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on May 17, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":37578,"derivative":{"exercise_price":5.48,"expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":37578},"source":{"system":"sec-edgar","filing":"0000950170-24-063017","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017024063017/ownership.xml","form_type":"4"}},{"id":1506843,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T20:53:14.000Z","date":"2024-05-17","kind":"grant","planned":false,"acquired":true,"shares":20529,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 17, 2025, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":49857,"source":{"system":"sec-edgar","filing":"0000950170-24-063017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000095017024063017/ownership.xml","form_type":"4"}},{"id":1809619,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-11T20:36:31.000Z","date":"2023-08-10","kind":"sale","planned":false,"acquired":false,"shares":6500,"price":6.0537,"value":39349.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.0952, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":29328,"source":{"system":"sec-edgar","filing":"0001209191-23-045447","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919123045447/doc4.xml","form_type":"4"}},{"id":1858475,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T20:19:37.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":33960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":33960,"derivative":{"exercise_price":6.5,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":33960},"source":{"system":"sec-edgar","filing":"0001209191-23-036285","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919123036285/doc4.xml","form_type":"4"}},{"id":1858474,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-12T20:19:37.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":17307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":35828,"source":{"system":"sec-edgar","filing":"0001209191-23-036285","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919123036285/doc4.xml","form_type":"4"}},{"id":2225073,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-21T20:55:04.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":24707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":24707,"derivative":{"exercise_price":9.37,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":24707},"source":{"system":"sec-edgar","filing":"0001209191-22-038448","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919122038448/doc4.xml","form_type":"4"}},{"id":2225072,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T20:55:04.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":12006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":18521,"source":{"system":"sec-edgar","filing":"0001209191-22-038448","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919122038448/doc4.xml","form_type":"4"}},{"id":2232363,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-15T00:37:31.000Z","date":"2022-06-13","kind":"sale","acquired":false,"shares":2700,"price":9.4789,"value":25593.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.431 to $9.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":6515,"source":{"system":"sec-edgar","filing":"0001209191-22-036835","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919122036835/doc4.xml","form_type":"4"}},{"id":2571833,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-13T20:40:15.000Z","date":"2021-09-09","kind":"exercise","acquired":false,"shares":13124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested with respect to 25% of the underlying shares on February 14, 2021, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date."}],"balance_after":21876,"derivative":{"exercise_price":12.7,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":13124},"source":{"system":"sec-edgar","filing":"0001209191-21-055685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121055685/doc4.xml","form_type":"4"}},{"id":2571832,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-13T20:40:15.000Z","date":"2021-09-09","kind":"exercise","acquired":false,"shares":5985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vested and became exercisable with respect to 100% of the option shares on June 11, 2021."}],"balance_after":0,"derivative":{"exercise_price":10.57,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":5985},"source":{"system":"sec-edgar","filing":"0001209191-21-055685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121055685/doc4.xml","form_type":"4"}},{"id":2571831,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-13T20:40:15.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":19109,"price":16.7448,"value":319976.3832,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"A portion of the shares was sold to satisfy the exercise price of the stock options."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.53 to $16.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":9215,"source":{"system":"sec-edgar","filing":"0001209191-21-055685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121055685/doc4.xml","form_type":"4"}},{"id":2571830,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-13T20:40:15.000Z","date":"2021-09-09","kind":"exercise","acquired":true,"shares":13124,"price":12.7,"value":166674.8,"ownership":{"direct":true},"balance_after":28324,"source":{"system":"sec-edgar","filing":"0001209191-21-055685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121055685/doc4.xml","form_type":"4"}},{"id":2571829,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-13T20:40:15.000Z","date":"2021-09-09","kind":"exercise","acquired":true,"shares":5985,"price":10.57,"value":63261.45,"ownership":{"direct":true},"balance_after":15200,"source":{"system":"sec-edgar","filing":"0001209191-21-055685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121055685/doc4.xml","form_type":"4"}},{"id":2663144,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T21:01:10.000Z","date":"2021-06-15","kind":"exercise","acquired":false,"shares":4015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vested and became exercisable with respect to 100% of the option shares on June 11, 2021."}],"balance_after":5985,"derivative":{"exercise_price":10.57,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":4015},"source":{"system":"sec-edgar","filing":"0001209191-21-041496","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121041496/doc4.xml","form_type":"4"}},{"id":2663143,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T21:01:10.000Z","date":"2021-06-15","kind":"sale","acquired":false,"shares":5000,"price":19.4244,"value":97122.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"A portion of the shares was sold to satisfy the exercise price of the stock option and the tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.40 to $19.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":9215,"source":{"system":"sec-edgar","filing":"0001209191-21-041496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121041496/doc4.xml","form_type":"4"}},{"id":2663142,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T21:01:10.000Z","date":"2021-06-15","kind":"exercise","acquired":true,"shares":4015,"price":10.57,"value":42438.55,"ownership":{"direct":true},"balance_after":14215,"source":{"system":"sec-edgar","filing":"0001209191-21-041496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121041496/doc4.xml","form_type":"4"}},{"id":2669806,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T20:36:04.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":10000,"derivative":{"exercise_price":19.21,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-040240","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121040240/doc4.xml","form_type":"4"}},{"id":2669805,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-14T20:36:04.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":10200,"source":{"system":"sec-edgar","filing":"0001209191-21-040240","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919121040240/doc4.xml","form_type":"4"}},{"id":3110194,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-15T23:11:42.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 100% of the option shares on June 11, 2021, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":10000,"derivative":{"exercise_price":10.57,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-036783","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120036783/doc4.xml","form_type":"4"}},{"id":3110193,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-15T23:11:42.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 11, 2021, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date."}],"balance_after":5200,"source":{"system":"sec-edgar","filing":"0001209191-20-036783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120036783/doc4.xml","form_type":"4"}},{"id":3262408,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":40409,"kind":"person","name":"Mitchell Stephen Ray","position":1,"cik":"0001802653","reported_name":"Mitchell Stephen Ray","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-02-19T21:20:34.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests with respect to 25% of the underlying shares when the Reporting Person completes 12 months of continuous service following the date of grant, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date."}],"balance_after":35000,"derivative":{"exercise_price":12.7,"expiration_date":"2030-02-13","underlying":"Common","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-010516","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120010516/doc4.xml","form_type":"4"}}]}